Literature DB >> 9378924

Complicated urinary tract infections.

A R Ronald1, G K Harding.   

Abstract

Urinary infections complicated by structural anomalies, metabolic alterations, abnormalities of host response, or unusual or difficult-to-treat pathogens commonly occur in our practices. Therapeutic regimens for most of these patient populations are empiric and unproven. Our understanding of specific microbial virulence factors is inadequate. Until well-designed interventions are proven, management strategies will depend on clinical biases and "trial and error" therapeutic attempts. Presumably, over the course of the next decade, better answers will emerge that will improve our ability to prevent and more adequately manage our patients with complicated UTIs.

Entities:  

Mesh:

Year:  1997        PMID: 9378924     DOI: 10.1016/s0891-5520(05)70374-3

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  12 in total

Review 1.  The quinolones and renal infection.

Authors:  A Ronald
Journal:  Drugs       Date:  1999       Impact factor: 9.546

2.  Propensity-matched analysis to compare the therapeutic efficacies of cefuroxime versus cefotaxime as initial antimicrobial therapy for community-onset complicated nonobstructive acute pyelonephritis due to Enterobacteriaceae infection in women.

Authors:  U-Im Chang; Hyung Wook Kim; Seong-Heon Wie
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

3.  Approach to urinary tract infections.

Authors:  M S Najar; C L Saldanha; K A Banday
Journal:  Indian J Nephrol       Date:  2009-10

Review 4.  Role of fluoroquinolones in the treatment of serious bacterial urinary tract infections.

Authors:  Culley Carson; Kurt G Naber
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 5.  Management of bacterial urinary tract infections in adult patients with diabetes mellitus.

Authors:  Ruby Meiland; Suzanne E Geerlings; Andy I M Hoepelman
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Urinary tract infection in women: new pathogenic considerations.

Authors:  Ann E Stapleton
Journal:  Curr Infect Dis Rep       Date:  2006-11       Impact factor: 3.663

7.  Change of antimicrobial susceptibility among Escherichia coli strains isolated from female patients with community-onset acute pyelonephritis.

Authors:  Seung-Kwan Lim; In Whee Park; Wee Gyo Lee; Hyun Kyung Kim; Young Hwa Choi
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

8.  Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis.

Authors:  Jessina C McGregor; George P Allen; David T Bearden
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

9.  The influence of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in elderly adult patients with urinary tract infection.

Authors:  Mario Bonadio; Silvia Costarelli; Giovanna Morelli; Tiziana Tartaglia
Journal:  BMC Infect Dis       Date:  2006-03-17       Impact factor: 3.090

10.  Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis.

Authors:  U-Im Chang; Hyung Wook Kim; Seong-Heon Wie
Journal:  Yonsei Med J       Date:  2015-09       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.